LOS ANGELES, March 11, 2025 /PRNewswire/ — Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against GSK plc. (“GSK” or the “Company”) (NYSE: GSK). IF YOU SUFFERED A LOSS ON YOUR GSK INVESTMENTS, CLICK HERE…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.